Quick Answer
HeartSciences Inc. reported Diluted EPS of $9.34 per share (loss) for fiscal year 2025.
HeartSciences Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$9.34 | +50.2% |
| 2024 | -$18.74 | +76.6% |
| 2023 | -$80.00 | -5417.2% |
| 2022 | -$1.45 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | -$0.85 | +62.6% | +46.2% |
| July 31, 2025 | -$1.58 | +40.2% | +38.5% |
| January 31, 2025 | -$2.57 | +14.6% | -13.2% |
| October 31, 2024 | -$2.27 | +85.7% | +14.0% |
| July 31, 2024 | -$2.64 | +80.0% | +12.3% |
| January 31, 2024 | -$3.01 | -1781.2% | +81.1% |
| October 31, 2023 | -$15.92 | -7136.4% | -20.3% |
| July 31, 2023 | -$13.23 | -4625.0% | -8168.8% |
- HeartSciences Inc. showed an increase of +50.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, HeartSciences Inc.’s diluted eps has declined by 544.1% (from $1.45 per share (loss) to $9.34 per share (loss)).
- The most recent figure is from HeartSciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: